These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11078190)

  • 21. Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat.
    Sarraf-Yazdi S; Sheng H; Miura Y; McFarlane C; Dexter F; Pearlstein R; Warner DS
    Anesth Analg; 1998 Jul; 87(1):72-8. PubMed ID: 9661549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and resolution of racemic eliprodil and evaluation of the enantiomers of eliprodil as NMDA receptor antagonists.
    Pabel J; Höfner G; Wanner KT
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1377-80. PubMed ID: 10890168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.
    Planells-Cases R; Montoliu C; Humet M; Fernández AM; García-Martínez C; Valera E; Merino JM; Pérez-Payá E; Messeguer A; Felipo V; Ferrer-Montiel A
    J Pharmacol Exp Ther; 2002 Jul; 302(1):163-73. PubMed ID: 12065713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivatives of dexanabinol. II. Salts of amino acid esters containing tertiary and quaternary heterocyclic nitrogen with increased water-solubility.
    Pop E; Soti F; Brewster ME; Barenholz Y; Korablyov V; Mechoulam R; Nadler V; Biegon A
    Pharm Res; 1996 Mar; 13(3):469-75. PubMed ID: 8692744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
    Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
    J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH
    Eur J Pharmacol; 1996 Oct; 314(3):307-11. PubMed ID: 8957251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
    Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
    J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK; Self J; Eshak M; Iannotti F
    Eur J Neurosci; 2000 Nov; 12(11):3833-42. PubMed ID: 11069578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide.
    Palmer GC; Murray RJ; Wilson TC; Eisman MS; Ray RK; Griffith RC; Napier JJ; Fedorchuk M; Stagnitto ML; Garske GE
    Epilepsy Res; 1992 Jun; 12(1):9-20. PubMed ID: 1388119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.
    Zucchini S; Buzzi A; Bergamaschi M; Pietra C; Villetti G; Simonato M
    Neuroreport; 2002 Nov; 13(16):2071-4. PubMed ID: 12438928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
    Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
    J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist.
    Fuchigami T; Haradahira T; Arai T; Okauchi T; Maeda J; Suzuki K; Yamamoto F; Suhara T; Sasaki S; Maeda M
    Biol Pharm Bull; 2003 Nov; 26(11):1570-3. PubMed ID: 14600403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activity.
    Stutzmann JM; Vuilhorgne M; Mignani S
    Mini Rev Med Chem; 2004 Feb; 4(2):123-40. PubMed ID: 14965286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists.
    De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Quartarone S; Zappalà M
    Bioorg Med Chem Lett; 1998 Apr; 8(8):971-6. PubMed ID: 9871522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.